Enhancement of chondrogenic differentiation potential of equine adiposetissue-derived mesenchymal stem cells using TGF-ß3 and BMP-6

Enhancement of chondrogenic differentiation potential of equine adiposetissue-derived mesenchymal stem cells using TGF-ß3 and BMP-6

This study was designed to evaluate the in vitro chondrogenic differentiation potential of equine adipose tissue-derived mesenchymal stem cells (AT-MSCs) in response to different culture conditions. Fat tissue cells after collection were cultured in optimized conditions until passage 3 (P3). P3 cells were cultured as micropellets under different chondrogenic conditions for 21 days in 5 groups: basic medium as a control, basic chondrogenic medium (BCM), BCM supplemented with transforming growth factor beta 3 (TGF-β3; 10 ng/mL), BCM supplemented with bone morphogenetic protein 6 (BMP-6; 10 ng/mL), and BCM supplemented with both TGF-β3 and BMP-6. The growth rate of pellets was measured and differentiation progression was assessed by specific stainings and gene expression profiling. Results showed that the largest pellets of cells belonged to the group containing both growth factors. All treated cells showed different levels of chondrogenic differentiation compared to the control group (P < 0.05). The differentiation score in groups containing TGF-β3 and both growth factors was significantly greater than that in other groups. Moreover, the expression of aggrecan, as a cartilage-specific gene, was confirmed in all groups expect the control group. Taken together, these results indicate that the addition of both TGF-β3 and BMP-6 to BCM potentiates the chondrogenic differentiation of equine AT-MSCs.

___

  • Alipour F, Parham A, Kazemi Mehrjerdi H, Dehghani H (2014). Equine adipose-derived mesenchymal stem cells: phenotype and growth characteristics, gene expression profile and differentiation potentials. Cell J 16: 456–465.
  • Alves AG, Stewart AA, Dudhia J, Kasashima Y, Goodship AE, Smith RK (2011). Cell-based therapies for tendon and ligament injuries. Vet Clin North Am Equine Pract 27: 315–315.
  • Arnhold SJ, Goletz I, Klein H, Stumpf G (2007). Isolation and characterization of bone marrow-derived equine mesenchymal stem cells. Am J Vet Res 68: 1095–1105.
  • Baksh D, Song L, Tuan RS (2004). Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8: 301–316.
  • Burk J, Ribitsch I, Gittel C, Juelke H, Kasper C, Staszyk C, Brehm W (2013). Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources. Vet J 195: 98–106.
  • Calloni R, Viegas GS, Türck P, Bonatto D, Pegas Henriques JA (2014). Mesenchymal stromal cells from unconventional model organisms. Cytotherapy 16: 3–16.
  • Co C, Vickaryous MK, Koch TG (2014). Membrane culture and reduced oxygen tension enhances cartilage matrix formation from equine cord blood mesenchymal stromal cells in vitro. Osteoarthr Cartilage 22: 472–480.
  • De Schauwer C, Meyer E, Van de Walle GR, Van Soom A (2011). Markers of stemness in equine mesenchymal stem cells: a plea for uniformity. Theriogenology 75: 1431–1443.
  • Dragoo JL, Carlson G, McCormick F, Khan-Farooqi H, Zhu M, Zuk PA, Benhaim P (2007). Healing full-thickness cartilage defects using adipose-derived stem cells. Tissue Eng 13: 1615–1621.
  • Estes BT, Wu AW, Guilak F (2006). Potent induction of chondrocytic differentiation of human adipose‐derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum 54: 1222– 1232.
  • Fortier LA, Nixon AJ, Williams J, Cable CS (1998). Isolation and chondrocytic differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res 59: 1182–1187.
  • Giovannini S, Brehm W, Mainil-Varlet P, Nesic D (2008). Multilineage differentiation potential of equine blood-derived fibroblast-like cells. Differentiation 76: 118–129.
  • Hegewald AA, Ringe J, Bartel J, Krüger I (2004). Hyaluronic acid and autologous synovial fluid induce chondrogenic differentiation of equine mesenchymal stem cells: a preliminary study. Tissue Cell 36: 431–438.
  • Hennig T, Lorenz H, Thiel A, Goetzke K, Dickhut A, Geiger F, Richter W (2007). Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFβ receptor and BMP profile and is overcome by BMP‐6. J Cell Physiol 211: 682–691.
  • Koch T, Heerkens T, Thomsen P, Betts D (2007). Isolation of mesenchymal stem cells from equine umbilical cord blood. BMC Biotechnol 7: 26.
  • Niyaz M, Gürpinar ÖA, Günaydin S, Onur MA (2012). Isolation, culturing and characterization of rat adipose tissue-derived mesenchymal stem cells: a simple technique. Turk J Biol 36: 658–664.
  • Park A, Hogan MV, Kesturu GS, James R, Balian G, Chhabra AB (2010). Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers. Tissue Eng Part A 16: 2941–2951.
  • Penny J, Harris P, Shakesheff KM, Mobasheri A (2012). The biology of equine mesenchymal stem cells: phenotypic characterization, cell surface markers and multilineage differentiation. Front Biosci 17: 892–908.
  • Pogue R, Lyons K (2006). BMP signaling in the cartilage growth plate. Curr Top Dev Biol 76: 1–48.
  • Ribitsch I, Burk J, Delling U, Geißler C, Gittel C, Jülke H, Brehm W (2010). Basic science and clinical application of stem cells in veterinary medicine. Adv Biochem Eng Biotechnol 123: 219–263.
  • Sekiya I, Colter DC, Prockop DJ (2001). BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem Biophys Res Commun 284: 411–418.
  • Somoza RA, Welter JF, Correa D, Caplan AI (2014). Chondrogenic differentiation of Mesenchymal Stem Cells: challenges and unfulfilled expectations. Tissue Eng B Rev 20: 596–608.
  • Stewart AA, Byron CR, Pondenis H, Stewart MC (2007). Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. Am J Vet Res 68: 941–945.
  • Tapp H, Hanley EN Jr, Patt JC, Gruber HE (2009). Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Exp Biol Med 234: 1–9.
  • Vater C, Kasten P, Stiehler M (2011). Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater 7: 463–477.
  • Vidal MA, Kilroy GE, Lopez MJ, Johnson JR, Moore RM, Gimble JM (2007). Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Vet Surg 36: 613–622.
  • Vidal MA, Robinson SO, Lopez MJ, Paulsen DB, Borkhsenious O, Johnson JR, Moore RM, Gimble JM (2008). Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg 37: 713–724.
  • Worster AA, Brower‐Toland BD, Fortier LA (2001). Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-β1 in monolayer and insulin like growth factor-I in a three-dimensional matrix. J Orthop Res 9: 738–749.
  • Worster AA, Nixon AJ, Brower-Toland BD, Williams J (2000). Effect of transforming growth factor β1 on chondrogenic differentiation of cultured equine mesenchymal stem cells. Am J Vet Res 61: 1003–1010.
  • Zhang L, Su P, Xu C, Yang J, Yu W, Huang D (2010). Chondrogenic differentiation of human mesenchymal stem cells: a comparison between micromass and pellet culture systems. Biotechnol Lett 32: 1339–1346.
  • Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211–228